Ocugen Statistics
Total Valuation
Ocugen has a market cap or net worth of MXN 10.12 billion. The enterprise value is 10.38 billion.
| Market Cap | 10.12B |
| Enterprise Value | 10.38B |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 327.89M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +10.77% |
| Shares Change (QoQ) | +2.74% |
| Owned by Insiders (%) | 1.42% |
| Owned by Institutions (%) | 18.64% |
| Float | 323.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 127.42 |
| PB Ratio | -46.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.50 |
| EV / Sales | 132.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.09 |
Financial Position
The company has a current ratio of 1.06
| Current Ratio | 1.06 |
| Quick Ratio | 0.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.58 |
| Interest Coverage | -12.26 |
Financial Efficiency
Return on equity (ROE) is -776.89% and return on invested capital (ROIC) is -95.62%.
| Return on Equity (ROE) | -776.89% |
| Return on Assets (ROA) | -63.10% |
| Return on Invested Capital (ROIC) | -95.62% |
| Return on Capital Employed (ROCE) | -310.56% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 836,296 |
| Profits Per Employee | -12.86M |
| Employee Count | 95 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +156.63% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +156.63% |
| 50-Day Moving Average | 28.44 |
| 200-Day Moving Average | 22.52 |
| Relative Strength Index (RSI) | 62.05 |
| Average Volume (20 Days) | 1,171 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ocugen had revenue of MXN 79.45 million and -1.22 billion in losses. Loss per share was -4.14.
| Revenue | 79.45M |
| Gross Profit | 79.45M |
| Operating Income | -1.14B |
| Pretax Income | -1.22B |
| Net Income | -1.22B |
| EBITDA | -1.10B |
| EBIT | -1.14B |
| Loss Per Share | -4.14 |
Balance Sheet
The company has 334.34 million in cash and 596.70 million in debt, giving a net cash position of -262.36 million.
| Cash & Cash Equivalents | 334.34M |
| Total Debt | 596.70M |
| Net Cash | -262.36M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -219.03M |
| Book Value Per Share | -0.70 |
| Working Capital | 23.35M |
Cash Flow
In the last 12 months, operating cash flow was -1.03 billion and capital expenditures -3.33 million, giving a free cash flow of -1.03 billion.
| Operating Cash Flow | -1.03B |
| Capital Expenditures | -3.33M |
| Free Cash Flow | -1.03B |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,440.74% |
| Pretax Margin | -1,537.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ocugen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.77% |
| Shareholder Yield | -10.77% |
| Earnings Yield | -12.07% |
| FCF Yield | -10.16% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |